[{"address1": "2 Burlington Woods Drive", "address2": "Suite 100", "city": "Burlington", "state": "MA", "zip": "01803", "country": "United States", "phone": "781 552 4452", "website": "https://www.bonebiologics.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jeffrey  Frelick", "age": 58, "title": "CEO & President", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 354109, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Deina H. Walsh CPA", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 227054, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8008, "open": 0.8151, "dayLow": 0.81, "dayHigh": 0.8748, "regularMarketPreviousClose": 0.8008, "regularMarketOpen": 0.8151, "regularMarketDayLow": 0.81, "regularMarketDayHigh": 0.8748, "payoutRatio": 0.0, "beta": 0.931, "forwardPE": -0.37899542, "volume": 14061, "regularMarketVolume": 14061, "averageVolume": 222606, "averageVolume10days": 47300, "averageDailyVolume10Day": 47300, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 2714963, "fiftyTwoWeekLow": 0.708, "fiftyTwoWeekHigh": 4.25, "fiftyDayAverage": 0.99416, "twoHundredDayAverage": 1.3542, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -610166, "profitMargins": 0.0, "floatShares": 3223939, "sharesOutstanding": 3271040, "sharesShort": 193340, "sharesShortPriorMonth": 155013, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0591, "heldPercentInsiders": 0.021259999, "heldPercentInstitutions": 0.021429999, "shortRatio": 0.66, "shortPercentOfFloat": 0.059699997, "impliedSharesOutstanding": 3271040, "bookValue": 1.179, "priceToBook": 0.7039864, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -7324924, "trailingEps": -4.83, "forwardEps": -2.19, "lastSplitFactor": "1:8", "lastSplitDate": 1703030400, "52WeekChange": -0.62612617, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 0.83, "targetHighPrice": 16.5, "targetLowPrice": 16.5, "targetMeanPrice": 16.5, "targetMedianPrice": 16.5, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 3325131, "totalCashPerShare": 1.017, "totalDebt": 0, "quickRatio": 8.803, "currentRatio": 10.223, "returnOnAssets": -0.69402003, "returnOnEquity": -1.28714, "freeCashflow": -2726891, "operatingCashflow": -4124935, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BBLG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 3.6463485, "regularMarketPrice": 0.83, "longName": "Bone Biologics Corporation", "shortName": "Bone Biologics Corp", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1741995294, "regularMarketTime": 1741982401, "exchange": "NCM", "messageBoardId": "finmb_99330767", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 0.0, "postMarketPrice": 0.83, "postMarketChange": 0.0, "regularMarketChange": 0.029199958, "regularMarketDayRange": "0.81 - 0.8748", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 222606, "fiftyTwoWeekLowChange": 0.12199998, "fiftyTwoWeekLowChangePercent": 0.17231636, "fiftyTwoWeekRange": "0.708 - 4.25", "fiftyTwoWeekHighChange": -3.42, "fiftyTwoWeekHighChangePercent": -0.8047059, "fiftyTwoWeekChangePercent": -62.612617, "dividendDate": 1532390400, "earningsTimestamp": 1740603600, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.83, "epsForward": -2.19, "epsCurrentYear": -2.3, "priceEpsCurrentYear": -0.36086956, "fiftyDayAverageChange": -0.16416001, "fiftyDayAverageChangePercent": -0.16512434, "twoHundredDayAverageChange": -0.5242, "twoHundredDayAverageChangePercent": -0.38709202, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-13", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634131800000, "displayName": "Bone Biologics", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]